Shift in phospholipid and fatty acid contents accompanies brain myelination.
Level 5 - mechanism / opinion, no new human data
Preclinical animal and bench research (mouse brain tissue and cell analysis).
PubMed 36055603 · doi:10.1016/j.biochi.2022.08.010
What was done
Investigators conducted an ultra-high-performance liquid chromatography and high-resolution mass spectrometry lipidomic analysis on myelin-enriched fractions isolated from mouse brains. They compared two developmental stages: an early rapid myelination phase at postnatal day 15 (P15) and a late basal myelination phase at postnatal day 40 (P40). They also assessed the expression of lipid synthesis genes in maturing O4+ oligodendrocytes.
What was found
No quantitative values or effect sizes were reported in the abstract. Across development, myelination was accompanied by a decrease in phosphatidylcholine (PC) content and increases in phosphatidylethanolamine (PE), phosphatidylserine (PS), and phosphatidylinositol (PI) levels. These phospholipid subclasses showed an increased proportion of monounsaturated fatty acids (MUFAs). In parallel, maturing O4+ oligodendrocytes showed upregulated expression of genes involved in PE, PI, PS, and MUFA synthesis.
Why it matters
Identifying the specific phospholipid and fatty acid shifts during normal brain maturation provides baseline lipid markers for myelin integrity that may aid research into demyelinating diseases.
Limits
The study is limited to mouse models, and findings may not fully translate to human central nervous system myelination. The abstract does not disclose animal sample sizes, specific quantitative concentrations, or fold changes. Direct functional impacts of these lipidomic shifts on axonal conduction velocity or membrane biophysics were not reported.
Cited by
- context Approximately 70% of the human brain by dry weight is composed of lipids (fat).